文献速递肺结节与肺癌肺栓塞与肺血管病

肺癌筛查与偶发发现:美国胸科学会研究议程声明

Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement.
PubMed 文献 · Am J Respir Crit Care Med · 2025-01-01

美国胸科学会召集多学科专家组,综述低剂量CT肺癌筛查中偶发发现的相关文献,聚焦报告变异性与标准化、管理以及获益与危害评估,尤其关注心血管相关偶发发现;采用三轮改良德尔菲法确定研究优先问题,最终提出20个优先研究问题。

要点

  • 肺癌筛查低剂量CT可发现与肺癌无关的偶发发现,部分有临床意义需干预,部分无临床意义却致额外检查与焦虑。
  • 声明识别了偶发发现在报告、管理及冠状动脉钙化识别与报告方面的知识缺口。
  • 专家组初步提出36个研究问题,最终确定20个优先研究问题以推进偶发发现的评估与管理。

核心结论

  • 该声明提供了优先研究议程,以推进肺癌筛查中偶发发现的评估、管理和认知提升。

研究设计与样本

  • 美国胸科学会召集多学科专家组综述肺癌筛查低剂量CT中偶发发现的现有文献,聚焦报告变异性与标准化、管理及获益与危害评估。
  • 采用三轮改良德尔菲法对研究问题进行优先级排序。

主要发现

  • 声明识别了三方面知识缺口:偶发发现的报告、偶发发现的管理、肺癌筛查低剂量CT上冠状动脉钙化的识别与报告。
  • 专家组初步提出36个研究问题,最终确定20个优先研究问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Lung cancer screening with low-dose computed tomography (LDCT) may uncover incidental findings (IFs) unrelated to lung cancer. There may be potential benefits from identifying clinically significant IFs that warrant intervention and potential harms related to identifying IFs that are not clinically significant but may result in additional evaluation, clinician effort, patient anxiety, complications, and excess cost. Objectives: To identify knowledge and research gaps and develop and prioritize research questions to address the approach to and management of IFs. Methods: We convened a multidisciplinary panel to review the available literature on IFs detected in lung cancer screening LDCT examinations, focusing on variability and standardizing reporting, management of IFs, and evaluation of the benefits and harms of IFs, particularly cardiovascular-related IFs. We used a three-round modified Delphi process to prioritize research questions. Results: This statement identifies knowledge gaps in 1) reporting of IFs, 2) management of IFs, and 3) identifying and reporting coronary artery calcification found on lung cancer screening LDCT. Finally, we present the panel's initial 36 research questions and the final 20 prioritized questions. Conclusions: This statement provides a prioritized research agenda to further efforts focused on evaluating, managing, and increasing awareness of IFs in lung cancer screening.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Henderson LM, Kim RY, Tanner NT, et al. Lung Cancer Screening and Incidental Findings: A Research Agenda: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2025. PMID: 39928329. doi:10.1164/rccm.202501-0011ST

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。